Tag: Phase
Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows
Pittsburgh, PA (PRWEB) June 01, 2015 Note: Dr. Julian is available for interviews today on this new development in breast cancer prevention. A phase III trial funded by the National Institutes of Health suggests that postmenopausal women with ductal carcinoma in situ (DCIS) now have an additional tool for breast cancer treatment and prevention. […]
Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with sorafenib, in patients with advanced hepatocellular carcinoma (HCC). In an intent-to-treat (ITT) population, investigators […]